Position in BCRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$202,630
+$38,140 QoQ
Shares Held
20,263
-6.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#204
of 316 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026R Squared Ltd holds $1,419,676 across 8 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
50,307 | $469,364 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
27,065 | $395,960 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
20,263 | $202,630 | |
| 4 | LFCR |
Lifecore Biomedical, Inc. De
|
24,580 | $129,045 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
27,861 | $125,095 | |
| 6 | SIGA |
Siga Technologies Inc
|
14,793 | $53,846 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
25,295 | $28,836 | |
| 8 | ADCT |
ADC Therapeutics SA
|
13,926 | $14,900 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,630 | 20,263 | Shares | Sole | 2026-08-05 | |
| 2025-09-30 | $164,490 | 21,672 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $87,525 | 11,670 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $47,639 | 6,335 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||